Open AccessSeminoma of testis with isolated bony metastasis at presentation
Author(s) -
Ankita Pandey,
Sunil Choudhary,
ChandraPrakash Verma,
Nilesh Mani
Publication year - 2023
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_1957_21
Subject(s) - seminoma , medicine , bleomycin , etoposide , metastasis , radiation therapy , radiology , testicular cancer , presentation (obstetrics) , positron emission tomography , lung , stage (stratigraphy) , chemotherapy , surgery , cancer , paleontology , biology
Germ cell tumor (GCT) comprises more than 95% of cases of all testicular tumor. Seminomas are a type of GCT where majority of patient presents with favorable outcome. Metastasis to nonpulmonary are rare scenarios and are grouped as intermediate risk. Most of the patients relapse in pulmonary or nonpulmonary sites within 2 years of treatment completion. However, bony metastasis (BM) on presentation is a rare condition. Here, we report a case of 37-year-old man diagnosed with stage I seminoma and underwent orchidectomy. Positron-emission tomography computed tomography scan after surgery revealed isolated bony metastasis in the left sacrum. Based on this, confirmatory diagnosis of Stage IIIc seminoma was made for which he received four cycles of bleomycin, etoposide, and cisplatin followed by palliative Radiotherapy (RT) to the metastatic region. After 1 year of follow-up, the patient is well and alive with no symptoms.